Colleen Donnelly

Ms. Colleen Donnelly

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
CDColleen Donnelly
Colleen Donnelly
LELissette Estrella
Lissette Estrella
IGIlona Ginevic
Ilona Ginevic
JGJaya Ganesh
Jaya Ganesh
DNAJC12-deficient hyperphenylalaninemia is a recently described inborn error of metabolism associated with hyperphenylalaninemia, neurotransmitter deficiency, and developmental delay caused by biallelic pathogenic variants of the DNAJC12 gene. The loss of the DNAJC12-encoded chaperone results in the destabilization of the biopterin-dependent aromatic amino acid hydroxylases, resulting in deficiencies in dopamine, norepinephrine, and serotonin. We present the case of a patient who screened positive for hyperphenylalaninemia on newborn screening and was discovered to be homozygous for a likely pathogenic variant of DNAJC12. Here, we review the management of DNAJC12-related hyperphenylalaninemia and compare our patient to other reported cases in the literature to investigate how early detection and management may impact clinical outcomes.

21 March 2022 in Genetics in Medicine
Verified
Journal Article
Closed access
CDColleen Donnelly
Colleen Donnelly
JGJaya Ganesh
Jaya Ganesh
ECEmalyn Cork
Emalyn Cork
LELissette Estrella
Lissette Estrella
IGIlona Ginevic
Ilona Ginevic
SMSuzanne Miller
Suzanne Miller

4 November 2025 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
VSVinaya Simha
Vinaya Simha
MLMary Kate LoPiccolo
Mary Kate LoPiccolo
APAnna Platt
Anna Platt
RBRebecca J. Brown
Rebecca J. Brown
XJXandria Johnson
Xandria Johnson
AGAbhimanyu Garg
Abhimanyu Garg
We report a novel variant in ACAA2 that causes hepatitis and hypoglycemia during infancy and lipodystrophy during adulthood accompanied by elevated plasma long chain acylcarnitines.

Verified
Journal Article
Open access
PDF file
DSDaniel Ross Schecter
Daniel Ross Schecter
CDColleen Donnelly
Colleen Donnelly
Amy WhiteAmy White
Amy White
HRHILLARY R RAYNES
HILLARY R RAYNES
GHGordon Heller
Gordon Heller
JGJaya Ganesh
Jaya Ganesh
Krabbe disease is an autosomal recessive leukodystrophy caused by a deficiency of the lysosomal enzyme galactosylceramidase (GALC), responsible for the degradation of galactolipids, resulting in toxic psychosine accumulation and progressive demyelination of the central and peripheral nervous systems. Newborn screening (NBS) has increased recognition of later-onset Krabbe disease, although interpretation of complex GALC genotypes remains challenging, particularly in the presence of “pseudodeficiency” and modifier alleles. In this case report, we describe a child with late-infantile Krabbe disease identified through NBS with markedly reduced GALC activity and a homozygous GALC haplotype containing c.956A>G (p.Tyr319Cys; Y319C) and c.1685T>C (p.Ile562Thr; I562T), in addition to other benign variants. Retrospective analysis of the newborn screening specimen demonstrated mild psychosine elevation. Despite preserved neurodevelopment, longitudinal surveillance demonstrated progressive cerebral white matter abnormalities by 3 years and 9 months of age and psychosine elevation in erythrocytes (14 pmol/g Hb; controls < 5), prompting umbilical cord blood transplantation (UCBT). Following transplantation, GALC enzyme activity normalized, psychosine levels decreased, and serial neuroimaging demonstrated radiographic stability without neurologic regression at last follow-up (9 years old). This case expands the phenotypic spectrum associated with homozygosity for the p.Tyr319Cys variant and highlights the role of p.Ile562Thr in amplifying the pathogenic potential when in cis with p.Tyr319Cys. This GALC haplotype illustrates how “pseudodeficiency” and modifier alleles may collectively influence biochemical, radiologic, and clinical disease expression. These findings emphasize the importance of integrating genotype, psychosine, enzyme activity, and longitudinal neuroimaging when evaluating infants with NBS results positive for Krabbe disease.


17 June 2026
Verified
Other
Open access
MNManish Neupane
Manish Neupane
MKMukesh Kumar
Mukesh Kumar
MMMalela A. Mwamufiya
Malela A. Mwamufiya
CDColleen Donnelly
Colleen Donnelly
AIAlsu Ibragimova
Alsu Ibragimova
DSDaniel P. Silver
Daniel P. Silver
Supplementary Figure S1 shows the effect of HDAC inhibitors on MECP2 protein levels